Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) (MSCIMS)

This study has been completed.
Cambridge University Hospitals NHS Foundation Trust
Medical Research Council
Information provided by (Responsible Party):
Peter Connick, University of Cambridge Identifier:
First received: November 1, 2006
Last updated: October 22, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):